Lv32
320 积分 2023-10-12 加入
Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain
3小时前
待确认
Systemic immunity in cancer
3个月前
已完结
The present and future of bispecific antibodies for cancer therapy
4个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
4个月前
已完结
Dual-target Bridging ELISA for Bispecific Antibodies
4个月前
已完结
Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes
4个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
6个月前
已完结
Latent Membrane Protein 2 (LMP2)
7个月前
已完结
Latent Membrane Protein 2 (LMP2)
7个月前
已关闭
To degrade or not to degrade: mechanisms and significance of endocytic recycling
8个月前
已完结
皖公网安备34019202002308
